secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001493152-23-037572
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 3.02, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics raises $5.0M through sale of Series A-1 Convertible Preferred Stock
--------------------------------------------------------------------------------

- Sold 5,000 Series A-1 Preferred shares at $1,000/share to accredited investors; gross proceeds of $5.0M closed Oct 18, 2023.
- Preferred convertible after 6 months at initial conversion price of $1.2592; mandatory conversion on Oct 18, 2025.
- Dividends: 20% of conversion shares on Oct 18, 2024 and Oct 18, 2025; no voting rights; liquidation preference senior to common.
- Company filed Certificate of Designation with Delaware and entered into Registration Rights Agreement for resale of underlying common shares.
- Series A-1 ranks pari passu with existing Series A Preferred; beneficial ownership limitation of 4.99% (or 9.99% optional).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223037572/0001493152-23-037572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223037572/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer